powered by LeadingAge New York

Initiative to Reduce Use of Antipsychotic Medications

Between the end of 2011 and the second quarter of 2014, the national prevalence of antipsychotic use in long-stay nursing home residents decreased from 23.9 percent to 19.4 percent nationwide. Success has varied by state and CMS region, with some states and regions having seen a reduction of greater than 20%.

New York ranked number 22 among the states in its reduction efforts, with its aggregate rates decreasing from 22% in the second quarter of 2011 to 17.6% in the second quarter of 2014; a 17.2% reduction overall. Read the trend update in its entirety here and review rates for each nursing home nationwide here.  

The National Partnership to Improve Dementia Care is now working with nursing homes to reduce the rates even further. They have established a new national goal of reducing the use of antipsychotic medications in long-stay nursing home residents 25 percent by the end of 2015, and 30 percent by the end of 2016.

LeadingAge New York nursing home members can easily track their long-stay antipsychotic rates over time using Nursing Home Quality Metrics, an interactive data tool available FREE to LeadingAge primary members. We are also conducting free Introductory and Intermediate Quality Metrics training webinars in December, so be sure to register soon. 

Contact: Kathy Pellatt, kpellatt@leadingageny.org, 518-867-8848 or Linda Spokane, lspokane@leadingageny.org, 518-867-8857